United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-230_4e8dd02d-2263-78d0-e063-6294a90a5f0b
- Product NDC
- 72888-230
- Form
- CAPSULE
- Composition / generic term
- Topiramate
- Labeler
- Advagen Pharma Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250527
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (72888-230-05) · 72888-230-05
- 120 CAPSULE in 1 BOTTLE (72888-230-12) · 72888-230-12
- 30 CAPSULE in 1 BOTTLE (72888-230-30) · 72888-230-30
- 60 CAPSULE in 1 BOTTLE (72888-230-60) · 72888-230-60
- 240 CAPSULE in 1 BOTTLE (72888-230-67) · 72888-230-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →